A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ferring Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01292109
First received: February 8, 2011
Last updated: February 8, 2012
Last verified: February 2012

February 8, 2011
February 8, 2012
December 2010
September 2011   (final data collection date for primary outcome measure)
Documentation of use PICOPREP in everyday practice [ Time Frame: Day 0 - 2 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01292109 on ClinicalTrials.gov Archive Site
  • Participant satisfaction and compliance after bowel cleansing [ Time Frame: Days 0-2 ] [ Designated as safety issue: No ]
  • Participants with adverse events reported by frequency and severity [ Time Frame: Days 1-2 ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.
Compliance and Efficacy in the Use of PICOPREP for Bowel Cleansing

The study serves as a confirmation of safety, tolerance and efficacy of PICOPREP in clinical practice.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients about to undergo X-ray examination, endoscopy or surgery.

Bowel Cleanliness
Drug: sodium picosulphate
Sodium picosulphate (PICOPREP®) taken by participant prior to X-ray examination, endoscopy or surgery.
Other Name: PICOPREP®
PICOPREP®
Intervention: Drug: sodium picosulphate
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
252
February 2012
September 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients receiving PICOPREP® for bowel evacuation prior to endoscopy or surgery

Exclusion Criteria:

  • Patients in which prescription of PICOPREP® is contraindicated
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Czech Republic
 
NCT01292109
FE999169 CS03
No
Ferring Pharmaceuticals
Ferring Pharmaceuticals
Not Provided
Study Director: Clinical Development Support Ferring Pharmaceuticals
Ferring Pharmaceuticals
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP